BIS Monitor Anesthesia for Neurocognitive Disorder
(POEGEA Trial)
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Research suggests that EEG-guided anesthesia, which uses brain activity monitoring, can reduce the risk of patients becoming aware during surgery. However, there is not enough evidence to show it prevents neurocognitive disorders or improves long-term outcomes after surgery.
12345Research shows that using the BIS monitor during anesthesia can help reduce the amount of anesthesia needed and speed up recovery, which suggests it is generally safe. It also helps prevent anesthesia awareness, a serious complication, indicating its safety in monitoring anesthesia levels.
46789EEG-guided anesthesia, using the Bispectral Index (BIS), is unique because it monitors brain activity to ensure the right depth of anesthesia, reducing the risk of awareness during surgery. This approach is different from standard methods that rely solely on anesthetic gas levels, offering a more precise way to manage anesthesia.
1491011Eligibility Criteria
This trial is for patients aged 70 or older who are undergoing major non-cardiac surgery and have an expected anesthesia time over 60 minutes. They must be able to communicate in English or French, without severe cognitive impairments from conditions like dementia, and not require emergency surgery.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo EEG-guided or standard care anesthesia during major non-cardiac surgery
Postoperative Monitoring
Participants are assessed for neurocognitive disorders and other outcomes at multiple postoperative timepoints
Follow-up
Participants are monitored for long-term cognitive outcomes and quality of life